| ADAM | a disintegrin and metalloproteinase |
| AFP | α-fetoprotein |
| BCLC | Barcelona Clinic Liver Cancer |
| EGFR | epidermal growth factor receptor |
| EMT | epithelial to mesenchymal transition |
| ERK | extracellular-signal regulated kinase |
| FLT3 | FMS-like tyrosine kinase |
| Gas6 | growth arrest specific gene 6 |
| GVHD | graft versus host disease |
| HB-EGF | heparin-binding EGF-like growth factor |
| HBV | hepatitis B virus |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis C virus |
| HER | human epidermal growth factor receptor |
| HIF | hypoxia- inducible factor |
| HSC | hepatic stellate cell |
| I/R | ischemia/reperfusion |
| ICD | intracellular domain |
| IFN | interferon |
| IFNAR | interferon α/β receptor |
| IL | interleukin |
| JAK/STAT | Janus kinase/signal transducers and activators of transcription |
| JNK | c-Jun-N-terminal kinase |
| KO | knock-out |
| MAPK | mitogen activated protein kinase |
| MAPKi | inhibition of the MAPK pathway |
| MCP | monocyte chemotactic protein |
| MMP | matrix metalloprotease |
| NAFLD | non-alcoholic fatty liver disease |
| NASH | non-alcoholic steatohepatitis |
| NF-κB | nuclear factor κ-light-chain-enhancer of activated B cells |
| NK | natural killer |
| PDGFR | platelet-derived growth factor receptor |
| PI3K | phosphoinositide 3-kinase |
| PKC | protein kinase C |
| ProS | Protein S |
| RTK | receptor tyrosine kinase |
| sAxl | soluble Axl |
| sIL-6R | soluble interleukin-6 receptor |
| SOCS | suppressors of cytokine signaling |
| TAM | Tyro3, Axl, Mer |
| TGF | transforming growth factor |
| TKi | tyrosine kinase inhibitors |
| TLR | Toll-like receptor |
| TME | tumor microenvironment |
| TNF | tumor necrosis factor |
| VEGFR | vascular endothelial growth factor receptor |
| YAP | Yes-associated protein |